Page 9 - Core One News Today

Core One Labs Provides Clarification on Trading Activity ACCESSWIRE VANCOUVER, BC / ACCESSWIRE / May 21, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the Company or Core One). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada ( IIROC) and the Canadian Securities Exchange ( CSE). Statements made in the news release issued by the Company on May 4, 2021 indicated that the Company had been made aware of pot...

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company” or “ Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“ Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products. Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he special...

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company” or “ Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“ Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products. Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he special...

Published: May 05, 2021 Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company” or “ Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“ Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products. Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá...

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has completed the acquisition (the “Transaction”) of Akome Biotech Ltd. (“Akome”). With this strategic acquisition, the scope of Core One’s psychedelics’ bio...

(1) VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce it has appointed Dr. Dan Polonenko to its Advisory Board, effective immediately. Dr. Polonenko has also agreed to consult the Company and will assist in the filing of any patents the Company intends to file. Dr. Polonenko is a Principal and Registered Patent Agent in Gowling WLGs Calgary office. His practice involves patent drafting and pr...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for ... Core One Labs Inc.April 21, 2021 GMT VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”) a life sciences research and technology company focused on bringing psychedelic medicine...

VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") a biotechnology research and development life sciences enterprise focused

Core One Labs Inc.: Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp. Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the " Company" or " Core One") announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) (" PBIC") to rescind the share exchange transaction previously completed between the parties (the " Share Exchange"). Effective March 16, 2020, the Company subscribed fo...